Literature DB >> 27496975

Critique of World Health Organization Recommendation of a Dengue Vaccine.

Scott B Halstead1.   

Abstract

Keywords:  antibody dependent enhancement (ADE); dengue vaccine; dengue virus; pathogenesis; safety; vaccine; vaccine adverse event

Mesh：

Substances：

Year:  2016        PMID： 27496975     DOI： 10.1093/infdis/jiw340

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  23 in total

Review 1.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner.

Authors:  Scott B Halstead
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2. 

Authors:  Bahaa Abu-Raya; Soren Gantt; Manish Sadarangani
Journal:  CMAJ       Date:  2020-11-30       Impact factor: 8.262

3.  Identification of small molecule inhibitors targeting the Zika virus envelope protein.

Authors:  Jared Pitts; Chih-Yun Hsia; Wenlong Lian; Jinhua Wang; Marc-Philipp Pfeil; Nicholas Kwiatkowski; Zhengnian Li; Jaebong Jang; Nathanael S Gray; Priscilla L Yang
Journal:  Antiviral Res       Date:  2019-02-13       Impact factor: 5.970

Review 4.  Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.

Authors:  Esteban Ortiz-Prado; Katherine Simbaña-Rivera; Lenin Gómez-Barreno; Mario Rubio-Neira; Linda P Guaman; Nikolaos C Kyriakidis; Claire Muslin; Ana María Gómez Jaramillo; Carlos Barba-Ostria; Doménica Cevallos-Robalino; Hugo Sanches-SanMiguel; Luis Unigarro; Rasa Zalakeviciute; Naomi Gadian; Andrés López-Cortés
Journal:  Diagn Microbiol Infect Dis       Date:  2020-05-30       Impact factor: 2.803

5.  Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.

Authors:  Wenlong Lian; Jaebong Jang; Supanee Potisopon; Pi-Chun Li; Amal Rahmeh; Jinhua Wang; Nicholas P Kwiatkowski; Nathanael S Gray; Priscilla L Yang
Journal:  ACS Infect Dis       Date:  2018-08-29       Impact factor: 5.084

6.  In silico targeting of non-structural 4B protein from dengue virus 4 with spiropyrazolopyridone: study of molecular dynamics simulation, ADMET and virtual screening.

Authors:  Waqar Hussain; Iqra Qaddir; Sajid Mahmood; Nouman Rasool
Journal:  Virusdisease       Date:  2018-03-29

7.  Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.

Authors:  Julia C Frei; Ariel S Wirchnianski; Jennifer Govero; Olivia Vergnolle; Kimberly A Dowd; Theodore C Pierson; Margaret Kielian; Mark E Girvin; Michael S Diamond; Jonathan R Lai
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

8.  Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.

Authors:  Naoko Uno; Ted M Ross
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

9.  Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.

Authors:  Wen-Yang Tsai; Hui-Ling Chen; Jih-Jin Tsai; Wanwisa Dejnirattisai; Amonrat Jumnainsong; Juthathip Mongkolsapaya; Gavin Screaton; James E Crowe; Wei-Kung Wang
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

10.  Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.

Authors:  Yang Yang; Ya Meng; M Elizabeth Halloran; Ira M Longini
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.